Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
02/16/2006 | WO2006016725A1 Photosensitive heterocyclic azo compound, process for producing the same, and optical information recording medium |
02/16/2006 | WO2006016680A1 Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac) |
02/16/2006 | WO2006015986A1 Mercaptoimidazoles as ccr2 receptor antagonists |
02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
02/16/2006 | WO2006015851A1 Piperazine derivatives with ccr3 inhibiting activity |
02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
02/16/2006 | WO2005108387A3 Cytokine inhibitors |
02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
02/16/2006 | WO2005080352A3 Quinazoline derivatives and therapeutic use thereof |
02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
02/16/2006 | US20060035934 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
02/16/2006 | US20060035933 Compounds having beta adrenergic receptor agonist and muscarinic receptor antagonist activity |
02/16/2006 | US20060035932 N-aryl piperidine compounds |
02/16/2006 | US20060035931 crystalline 1,2-ethanedisulfonic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester; treat a pulmonary disorder |
02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
02/16/2006 | DE102004035203A1 Substituierte Chinolone Substituted Quinolones |
02/16/2006 | CA2576667A1 Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac) |
02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
02/16/2006 | CA2575486A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
02/16/2006 | CA2574827A1 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
02/16/2006 | CA2574292A1 Piperazine derivatives with ccr3 inhibiting activity |
02/16/2006 | CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists |
02/16/2006 | CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
02/16/2006 | CA2572325A1 Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
02/15/2006 | EP1626047A1 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent |
02/15/2006 | EP1626044A1 Novel piperidine derivative |
02/15/2006 | EP1626043A1 Heterocyclic thioesters |
02/15/2006 | EP1625125A1 Compounds as crf1 receptor antagonists |
02/15/2006 | EP1625122A1 Dipeptidyl peptidase inhibitors |
02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
02/15/2006 | EP1625120A1 Chemical compounds |
02/15/2006 | EP1625119A1 Substituted-1-phthalazinamines as vr-1 antagonists |
02/15/2006 | EP1625114A1 Chemical compounds |
02/15/2006 | EP1041985B1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
02/15/2006 | EP1010423B1 Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production |
02/15/2006 | CN1735618A New tricyclic derivatives as LTD4 antagonists |
02/15/2006 | CN1735612A Anti-infective agents |
02/15/2006 | CN1735608A Substituted benzoyl derivatives as herbicides |
02/15/2006 | CN1735607A 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
02/15/2006 | CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
02/15/2006 | CN1735593A Novel CB1 receptour inverse agonists |
02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
02/15/2006 | CN1733758A Imide analog compounds and its preparation method |
02/15/2006 | CN1733757A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
02/14/2006 | US6998490 Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group |
02/14/2006 | US6998486 Process for production of cyclic diamine compounds or salts thereof |
02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
02/14/2006 | US6998403 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
02/14/2006 | US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
02/14/2006 | US6998233 Methods for ligand discovery |
02/14/2006 | CA2263167C Ether muscarinic antagonists |
02/14/2006 | CA2241186C Benzimidazole derivatives |
02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
02/14/2006 | CA2210044C 4-hydroxy-piperidine derivatives |
02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2180155C Naphthylamides as central nervous system agents |
02/14/2006 | CA2135926C Substituted hexahydrobenzo[a]phenanthridines |
02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
02/09/2006 | WO2006014877A2 Potassium channel inhibitors |
02/09/2006 | WO2006014482A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
02/09/2006 | WO2006014359A2 Compounds useful for inhibiting chk1 |
02/09/2006 | WO2006014290A2 Anti-inflammatory medicaments |
02/09/2006 | WO2006014136A1 Piperidine derivatives as histamine h3 receptor ligands |
02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
02/09/2006 | WO2006014005A1 Pyrazole derivative |
02/09/2006 | WO2006013960A1 Salts of benzimidazole derivative with amines and process for production thereof |
02/09/2006 | WO2006013393A2 Quinoline derivatives as neurokinin receptor antagonists |
02/09/2006 | WO2006013073A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
02/09/2006 | WO2005118558A3 Pyrimidine compounds and use thereof |
02/09/2006 | WO2005095409A3 Tetrahydroquinoline derivatives and a process for preparing the same |
02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
02/09/2006 | US20060030712 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
02/09/2006 | US20060030711 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
02/09/2006 | US20060030605 Pharmaceutical compounds |
02/09/2006 | US20060030601 Novel aminopyridine derivatives as mGluR5 antagonists |
02/09/2006 | US20060030595 Potassium channel inhibitors |
02/09/2006 | US20060030593 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
02/09/2006 | US20060030592 I-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
02/09/2006 | US20060030588 Heteroaryl urea neuropeptide Y Y5 receptor antagonists |
02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |